Limit investment risk in 2020

Published 13-DEC-2019 09:51 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The era of hands-on central banks and hands-off governments is set to reverse in 2020, and investors should expect a bumpy ride, as the rate at which risk translates into real portfolio impact increases.

This is the central premise of Principal Global Investors’ Chief Strategist, Seema Shah’s outlook for 2020, in which she outlines the five themes she believes will shape markets, and impact returns for investors next year.

Principal Global Investors® is a multi-boutique firm. It manages approximately $412.7 billion in assets on behalf of over 800 institutional clients located in over 80 countries as well as retirement plans and individual clients.

“Low rates may have saved us from economic disaster, but they have also distorted financial markets, crippled bank lending and threatened pension and superannuation systems worldwide,” Shah said.

“Nonetheless, rates and growth are likely to stay low for the foreseeable future, so the real question is how investors should respond."

Shah doesn’t anticipate a recession in the next 12 months, and expects the global economy to stabilise in early 2020. However, she does not expect a strong enough upturn to stop central banks from maintaining the monetary sugar rush to financial markets.

“Equities have had an amazing run - in part due to the amount of liquidity in the system – so while I expect the cash injections to persist, their diminishing effectiveness means we are likely to see multiple expansion, rather than earnings growth.

“The gap between fundamentals and valuations is already increasing – and although we expect stocks to remain relatively resilient next year, it’s difficult to see how they won’t start to look down with a feeling of rising nausea,” she said.

Shah said she also expects a pendulum swing from momentum to value stocks, and noted that the outperformance of defensive and growth stocks in 2019 is unlikely to continue.

“There’s no reason to dump momentum stocks en masse however, because a fundamental and sustained shift from momentum to value would require a stronger upturn in economic activity than anyone expects in 2020,” she said.

When asked for her asset class picks for 2020, Shah said that the low interest rate environment will persist, and that investors should remain fully invested, actively seeking out opportunities which offer positive returns but also limit portfolio risk.

“A core allocation to US mega cap stocks, a tactical allocation to value stocks, and fixed interest, including convertible bonds and emerging market debt which are both attractive sources of yield.

“I also like real estate as a defensive play – it’s a long-term asset class with different drivers and dynamics to global equity markets and is somewhat sheltered from downside risks.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X